From his updated map of sequencers, Nick Loman says that Illumina machines are still dominant — making up 60 percent of his sample — but that the race for second place is close. Roche, he says, has just nudged out SOLiD by eight machines.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.